ARCHIVE

• BUSINESS NEWS IN BRIEF
  March 3, 2003

• OTC NEWS IN BRIEF
  March 3, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  March 3, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  March 3, 2003

• CDFS Panel Recommends Approval of Chugai's Xeloda
  March 3, 2003

• Eisai to Donate Neuroscience Chair to Kyoto Univ
  March 3, 2003

• Korosho to Reduce Number of Long-term Pending NDAs
  March 3, 2003

• WORLD NEWS IN BRIEF
  March 3, 2003

• JIC Committee Recommends Measures to Encourage Investment in Japan
  March 3, 2003

• BULLETIN
  March 3, 2003

• Indications of Antibacterials to Be Reevaluated
  March 3, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  March 3, 2003

• REPORT
  March 3, 2003

• REGULATORY NEWS IN BRIEF
  March 3, 2003

• Physicians with Knowledge of Both Western and Oriental Medicine Needed: Kampo Symposium
  February 24, 2003

• Eli Lilly Conducts Trial on Switching from Typical to Atypical Antipsychotic Drugs
  February 24, 2003

• Pharma SNP Consortium to Complete Activities in May
  February 24, 2003

• Singulair's Share Up Since Approval of Long-term Prescription: Banyu
  February 24, 2003

• PRESS SEMINAR
  February 24, 2003

• Novo Nordisk Pharma to Focus Harder on Diabetes: President Moore
  February 24, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 615
• 616
• 617
• 618
• 619
• 620
• 621
• 622
• 623
• …
• Next ›
• 最終 »